LONDON/TOKYO (Reuters) - Japan's largest drugmaker Takeda Pharmaceutical is considering a bid for London-listed Shire that could top $40 billion and spark another takeover battle in the deal-hungry pharma industry.

Drugmaker Shire soars as Japan's Takeda considers bid
Read More
Bagikan Berita Ini
0 Response to "Drugmaker Shire soars as Japan's Takeda considers bid"
Posting Komentar